MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, IART made $402,062,000 in revenue. -$5,404,000 in net income. Net profit margin of -1.34%.

Income Overview

Revenue
$402,062,000
Net Income
-$5,404,000
Net Profit Margin
-1.34%
EPS
-$0.07
Unit: Dollar
Revenue Breakdown
    • Neurosurgery
    • Regenerative Skin And Wound
    • Instruments
    • Others
Revenue Breakdown
    • Codman Specialty Surgical
    • Tissue Technologies
Revenue Breakdown
    • US
    • Europe
    • Asia Pacific
    • Rest Of The World

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenue, net
402,062,000 415,605,000 382,653,000 409,897,666.667
Cost of goods sold
195,071,000 206,273,000 188,221,000 182,623,333.333
Research and development
22,456,000 26,997,000 24,728,000 29,314,000
Selling, general and administrative
169,046,000 179,890,000 181,497,000 179,930,000
Intangible asset amortization
3,728,000 3,754,000 3,704,000 5,843,333.333
Goodwill impairment charge
0 511,365,000 --
Total costs and expenses
390,301,000 928,279,000 398,150,000 397,710,666.667
Operating income (loss)
11,761,000 -512,674,000 -15,497,000 12,187,000
Interest income
4,982,000 4,710,000 4,420,000 4,997,000
Interest expense
22,725,000 21,042,000 18,815,000 17,086,333.333
Other (expense) income, net
-842,000 -1,946,000 -144,000 610,666.667
Loss before income taxes
-6,824,000 -530,952,000 -30,036,000 708,333.333
Benefit for income taxes
-1,420,000 -46,879,000 -4,743,000 -542,000
Net loss
-5,404,000 -484,073,000 -25,293,000 1,250,333.333
Basic (in dollars per share)
-0.07 -6.31 -0.33 0.017
Basic (in shares)
76,753,000 76,695,000 76,463,000 187,333.333
Diluted (in dollars per share)
-0.07 -6.31 -0.33 0.017
Diluted (in shares)
76,753,000 76,695,000 76,463,000 187,333.333
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Private Label$25,491,000 Regenerative Skin And Wound$83,988,000 ENT$40,869,000 Instruments$50,151,000 Neurosurgery$201,563,000 Tissue Technologies$109,479,000 Codman SpecialtySurgical$292,583,000 Net loss-$5,404,000 Benefit for income taxes-$1,420,000 Total revenue, net$402,062,000 Loss before incometaxes-$6,824,000 Interest income$4,982,000 Operating income (loss)$11,761,000 Total costs andexpenses$390,301,000 Other (expense)income, net-$842,000 Interest expense$22,725,000 Intangible assetamortization$3,728,000 Selling, general andadministrative$169,046,000 Research and development$22,456,000 Cost of goods sold$195,071,000

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

INTEGRA LIFESCIENCES HOLDINGS CORP (IART)